Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice.

[1]  Hu-Jang Lee,et al.  Interleukin 6 Promotes Brucella abortus Clearance by Controlling Bactericidal Activity of Macrophages and CD8+ T Cell Differentiation , 2019, Infection and Immunity.

[2]  O. Choudhary,et al.  Cytokines in brucellosis: biological rhythm at the interface of innate and adaptive immunity , 2019, Biological Rhythm Research.

[3]  V. Chalifa-Caspi,et al.  Streptococcus pneumoniae Cell Wall-Localized Trigger Factor Elicits a Protective Immune Response and Contributes to Bacterial Adhesion to the Host , 2019, Scientific Reports.

[4]  Hu-Jang Lee,et al.  Substantial Protective Immunity Conferred by a Combination of Brucella abortus Recombinant Proteins against Brucella abortus 544 Infection in BALB/c Mice. , 2019, Journal of microbiology and biotechnology.

[5]  Hu-Jang Lee,et al.  Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus. , 2018, Vaccine.

[6]  R. Krecek,et al.  Brucellosis remains a neglected disease in the developing world: a call for interdisciplinary action , 2018, BMC Public Health.

[7]  M. Rhee,et al.  Activation of NF-kB-Mediated TNF-Induced Antimicrobial Immunity Is Required for the Efficient Brucella abortus Clearance in RAW 264.7 Cells , 2017, Front. Cell. Infect. Microbiol..

[8]  Ying Chen,et al.  Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis , 2016, Journal of Molecular Medicine.

[9]  A. Teixeira-Carvalho,et al.  Immune response triggered by Brucella abortus following infection or vaccination. , 2015, Vaccine.

[10]  Jin Ju Lee,et al.  Immunoproteomic identification of immunodominant antigens independent of the time of infection in Brucella abortus 2308-challenged cattle , 2015, Veterinary Research.

[11]  Hu-Jang Lee,et al.  Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB/c mice. , 2015, FEMS microbiology letters.

[12]  P. Genevaux,et al.  Multitasking SecB chaperones in bacteria , 2014, Front. Microbiol..

[13]  Gilles Vergnaud,et al.  Brucella papionis sp. nov., isolated from baboons (Papio spp.). , 2014, International journal of systematic and evolutionary microbiology.

[14]  Jin Ju Lee,et al.  Proteomic analyses of the time course responses of mice infected with Brucella abortus 544 reveal immunogenic antigens. , 2014, FEMS microbiology letters.

[15]  M. Palmer,et al.  Advancement of Knowledge of Brucella Over the Past 50 Years , 2014, Veterinary pathology.

[16]  P. Boura,et al.  Immunity to brucellosis. , 2013, Revue scientifique et technique.

[17]  Anna R Martirosyan,et al.  Brucella evasion of adaptive immunity. , 2013, Future microbiology.

[18]  R. Yousefi-Nooraie,et al.  Antibiotics for treating human brucellosis. , 2012, The Cochrane database of systematic reviews.

[19]  E. Moreno,et al.  What have we learned from brucellosis in the mouse model? , 2012, Veterinary Research.

[20]  Y. He,et al.  Analyses of Brucella Pathogenesis, Host Immunity, and Vaccine Targets using Systems Biology and Bioinformatics , 2011, Front. Cell. Inf. Microbio..

[21]  Yan Wei,et al.  Coxiella burnetii antigen-stimulated dendritic cells mediated protection against Coxiella burnetii in BALB/c mice. , 2011, The Journal of infectious diseases.

[22]  L. Mathias,et al.  Clinical Manifestations of Brucellosis in Domestic Animals and Humans , 2010 .

[23]  R. L. Santos,et al.  Natural Antibody Contributes to Host Defense against an Attenuated Brucella abortus virB Mutant , 2009, Infection and Immunity.

[24]  S. Estein,et al.  Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection , 2008, Infection and Immunity.

[25]  Xinghong Yang,et al.  Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization. , 2007, Vaccine.

[26]  J. Celli.  Surviving inside a macrophage: the many ways of Brucella. , 2006, Research in microbiology.

[27]  Y. Singh,et al.  Nucleoside diphosphate kinase‐like activity in adenylate kinase of Mycobacterium tuberculosis , 2003, Biotechnology and applied biochemistry.

[28]  F. Goldbaum,et al.  Brucella Lumazine Synthase Elicits a Mixed Th1-Th2 Immune Response and Reduces Infection in Mice Challenged with Brucella abortus 544 Independently of the Adjuvant Formulation Used , 2003, Infection and Immunity.

[29]  Y. He,et al.  Brucella abortus RB51: enhancing vaccine efficacy and developing multivalent vaccines. , 2002, Veterinary microbiology.

[30]  J. Oliaro,et al.  The innate immune response against Brucella in humans. , 2002, Veterinary microbiology.

[31]  J. Letesson,et al.  Protection of BALB/c Mice against Brucella abortus 544 Challenge by Vaccination with Bacterioferritin or P39 Recombinant Proteins with CpG Oligodeoxynucleotides as Adjuvant , 2001, Infection and Immunity.

[32]  Vasu Punj,et al.  Adenylate Kinase as a Virulence Factor ofPseudomonas aeruginosa , 2001, Journal of bacteriology.

[33]  A. Driessen.  SecB, a molecular chaperone with two faces. , 2001, Trends in microbiology.

[34]  G. Splitter,et al.  Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. , 1996, Vaccine.

[35]  J. Cavaillon.  Cytokines and macrophages. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[36]  L. G. Adams,et al.  Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice , 1989, Infection and immunity.